Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides

Therapeutics and Clinical Risk Management

Volumn 4, Issue 5, 2008, Pages 1135-1141

  Breneman, Debra L ^a   Storer, Timothy J ^b   Breneman, John C ^a   Mutasim, Diya F ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b Smith Clinic   (United States)

Author keywords

Cutaneous T cell lymphoma; Methotrexate; Mycosis fungoides; Toxicity; Ulceration

Indexed keywords

CREATININE; ETOPOSIDE; FLUTAMIDE; FOLIC ACID; FUROSEMIDE; HYDROXYZINE; LORAZEPAM; METHOTREXATE; POTASSIUM CHLORIDE;

AGED; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHRODERMA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LYMPHOMA; MALE; MYCOSIS FUNGOIDES; SKIN BIOPSY; SKIN ULCER; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL;

EID: 56749148164     PISSN: 11766336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Aractingi S, Briant E, Marolleau JP, et al. 1992. Décollements cutane's induits par le méthotrexate. Presse Méd, 21:1668-70.
2. Baker H. 1970. Intermittent high-dose oral methotrexate therapy in psoriasis. Br J Dermatol, 82:65-9.
3. Ben-Amitai D, Hodak E, David M. 1998. Cutaneous ulceration: An unusual sign of methotrexate toxicity - first report in a patient without psoriasis. Ann Pharmacother, 32:651-3.
4. Kaplan DL, Olsen EA. 1988. Erosion of psoriatic plaques after chronic methotrexate administration. Int J Dermatol, 27:50-62.
5. Kazlow DW, Federgrun D, Kurtin S, et al. 2003. Cutaneous ulceration caused by methotrexate. J Am Acad Dermatol, 49:S197-8.
6. Lawrence C, Dahl M. 1982. Cutaneous necrosis associated with methotrexate treatment of psoriasis. Br J Dermatol, 107(Suppl 22):24.
7. Lawrence C, Dahl M. 1984. Two patterns of skin ulceration induced by methotrexate in patients with psoriasis. J Am Acad Dermatol, 11:1059-65.
8. McDonald CJ, Bertino JR. 1978. Treatment of mycosis fungoides: Effectiveness of infusions of methotrexate followed by oral citrovorum factor. Cancer Treat Rep, 62:1009-14.
9. Naldi L, Griffiths CEM. 2005. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: An assessment of the benefits and risks. Br J Dermatol, 152:597-615.
10. Olsen EA. 1991. The pharmacology of methotrexate. J Am Acad Dermatol, 25:306-18.
11. Pearce HP, Braunstein B. 1996. Erosion of psoriatic plaques: An early sign of methotrexate toxicity. J Am Acad Dermatology, 35:835-8.
12. Primka EJ, Carnisa C. 1997. Methotrexate-induced toxic epidermal necrolysis in a patient with psoriasis. J Am Acad Dermatol, 36:815-8.
13. Reed KM, Sober AJ. 1983. Methotrexate-induced necrolysis. J Am Acad Dermatol, 8:677-9.
14. Yang C, Yang LJ, Jaing TH, et al. 2000. Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole Int J Dermatol, 39:621-4.
15. Zackheim HS, Epstein EH Jr. 1989. Low-dose methotrexate for the Sézary syndrome. J Am Acad Dermatol, 21:757-62.
16. Zackheim HS, Kashani-Sabet M, Hwang ST. 1996. Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: Results in twenty-nine patients. J Am Acad Dermatol, 34:626-31.
17. Zackheim HS, Kashani-Sabet M, McMillan A. 2003. Low-dose methotrexate to treat mycosis fungoides: A retrospective study in 69 patients. J Am Acad Dermatol, 49:873-8.